Shimadzu unveils key products and innovations at AAPS 2026 PharmSCi 360

At the AAPS 2026 PharmSci 360 conference, taking place from October 25–28 in New Orleans, USA, Shimadzu will be showcasing its product innovations, core analytical suites, and tech-driven corporate initiatives that align directly with the conference's bioanalytics, manufacturing, and automation tracks.

Technologies on display at Booth 1204 include:

• The GCMS-TQ RX Series: a versatile triple quadrupole gas chromatograph mass spectrometer that combines stability, intuitive software, advanced automation and flexible workflows to help laboratories in pharmaceuticals, environmental testing, food safety, forensics, and other sectors meet evolving analytical demands with greater efficiency and confidence.
• Oligonucleotide characterization: Shimadzu is detailing intuitive software and LC-MS methods aimed at simplifying impurity detection and mass confirmation for synthetic oligonucleotides and advanced biotherapeutic modalities.
• Automated sample preparation partnerships: Highlighting their strategic North American collaboration with ePrep, Shimadzu is demonstrating automated end-to-end sample prep pipelines engineered to protect data integrity and optimize high-throughput workflows.
• Ultra-fast mass spectrometry (UFMS) and liquid chromatography platforms: The booth includes active technical showcases of Shimadzu's flagship next-generation systems, such as the Nexera Prep LC and advanced mass spectrometers calibrated for characterizing oligos and identifying complex drug impurities.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>